Board of Directors

Last modified: 7.11.2019

Board of Directors

Pursuant to the company’s Articles of Association, the Board of Directors shall comprise of a minimum of 5 and a maximum of 8 members. The Annual General Meeting elects the members of the Board of Directors. The term of office of the members of the Board of Directors will expire at the end of the next Annual General Meeting following the election.

The Board of Directors has general competence to decide and act in all matters not reserved for other corporate governing bodies by law or under the provisions of the company’s Articles of Association. The Board of Directors is responsible for the company’s administration and the appropriate organisation of its operations. The Board of Directors decides on company and group wide significant matters of principal importance. The Board of Directors appoints and dismisses the CEO, supervises his or her actions and decides on his or her remuneration and other terms and conditions of employment. The Board of Directors also makes decisions on the strategy, key investments, organisation and financial affairs of the company. In addition, the Board of Directors monitors and assesses the company’s financial performance and position and reviews and approves the company’s interim reports and financial statements. In all situations, the Board of Directors must act in accordance with the best interest of the company.

 

Petri Salonen

B. 1958, Finnish citizen
Chairman of the Board of Directors since 2006

Petri Salonen serves as the Chairman of the Board of Directors of Delfoi Ltd and as a member of the Boards of Directors of Aura Capital Oy and AW-Energy Oy. In addition, he serves as Sales Director at JAS Partners Oy. Previously, Mr. Salonen was the Chairman and a member of the Board of Directors of Commit; Oy (presently Optomed Software Oy), a member of the Boards of Directors of Chip-Man Technologies Ltd, IonPhasE Ltd and Silicon Laboratories Finland Inc, the Chief Executive Officer of Atbusiness Communications Oyj and Bluegiga Technologies Inc. and the Investment Director of Aura Capital Oy.

Education: Master of Science degree in Shipbuilding Technology, Naval Architecture and Marine Engineering from Aalto University.

 

Matthew Hallam

B. 1972, British citizen
Member of the Board of Directors since 2018

Matthew Hallam serves as the Finance Director of Keeler Ltd. Previously, Mr. Hallam served as EMEA Divisional Finance Director, Group Financial Planning and Analysis Manager and UK & Nordics Controller at Abbott Laboratories Inc, as well as Finance Manager at Guidant Ltd.

Education: Bachelor of Arts degree in Mathematics and Economics from the University of Liverpool.

 

Seppo Mäkinen

B. 1952, Finnish citizen
Member of the Board of Directors since 2019

Seppo Mäkinen serves as a member of the Boards of Directors of Bittium Corporation, Neurotar Ltd and Videovisit Ltd, as a deputy member of the Board of Directors of Noribe Group Oy and Taikon Advisor Oy and as Partner at Pathena SGPS. Previously, Mr. Mäkinen was the Chairman of the Boards of Directors of Taikon Advisor Oy and ValiFinn Ltd, and a member of the Board of Directors of ArcDia International Oy Ltd, Coimbra Genomics SA, Evondos ltd, Ginolis Oy, Magnasense Technologies Oy, Med Group Oy, Med Group Holding Oy and Valirx Oy. In addition, he has been Partner at Ventac Partners and Regional Partner at Mérieux Développement SAS, Founding and Managing Partner at BioFund Ventures and Director of Life Sciences at Sitra.

Education: Master of Science degree in Physical Chemistry from the University of Jyväskylä.

 

Ingo Ramesohl

B. 1969, German citizen
Member of the Board of Directors since 2018

Ingo Ramesohl serves as the Managing Director of Robert Bosch Venture Capital GmbH. Previously, Dr. Ramesohl served as Vice President of Robert Bosch GmbH, as General Manager at United Automotive Electronic Systems Co. Ltd, as Director at Korea Automotive Motor Cooperation (KAMCO), as well as other managerial positions at Robert Bosch GmbH.

Education: Doctoral degree in Electrical Engineering from RWTH Aachen University.

 

Reijo Tauriainen

B. 1956, Finnish citizen
Member of the Board of Directors since 2019

Reijo Tauriainen serves as the Chairman of the Boards of Directors of Arvo Invest Nordic Oy, Meka Pro Oy, Pohjanmaan Arvo Sijoitusosuuskunta and Unipro Oy Ltd, as a member of the Boards of Directors of Champion Door Oy, Hoivatilat Plc, Lapwall Oy, Nordic Option Oy, Propria Oy, Temotek Oy and Temotek Palvelut Oy. Previously, Mr. Tauriainen was the Chairman of the Boards of Directors of Nordic Option Oy, Oulun Ydinkeskustan Parkki Oy, Sanerall Group Oy, Technopolis Kiinteistöt Pääkaupunkiseutu Oy, Technopolis Kiinteistöt Oulu Oy and Technopolis Kiinteistöt Tampere Oy, the Chief Executive Officer of Pohjanmaan Arvo Sijoitusosuuskunta, and a member of the Board of Directors and the Chief Financial Officer of Uros Ltd and as the Deputy Chief Executive Officer and Chief Financial Officer of Technopolis Plc. In addition, he has served as a member of the Board of Directors of Technopolis Kuopio Oy, as a deputy member of the Board of Directors and the Chief Executive Officer of Technopolis Hitech Oy.

Education: Master of Science degree in Economics from the University of Oulu.

 

Anders Torstensson

B. 1956, Swedish citizen
Member of the Board of Directors since 2008

Anders Torstensson serves as the Chairman of the Board of Directors and the Chief Executive Officer of Mankato Management Services GmbH, and as the Chairman of the Boards of Directors of Aava Mobile Oy, Avanzia Communication Centre AG, Canoxa Capital AB, Catalunia Capital AB, Fuerte Holding AB, Kapitalio Financial Group AB, Kapitalio Financial Technologies AB, and Uppland Kapital AB. Furthermore, Mr. Torstensson also serves as a member of the Boards of Directors and the Chief Executive Officer of Mankato Capital Ltd and Upplandsspar AB and as a member of the Boards of Directors of Lendlink AB, Uppland Kredit AB (publ) and Virteco AB. In addition, he serves as the Chief Executive Officer of International Card Establishment Europe AB, Manager of Apptor Holding GmbH and is self-employed via his sole proprietorship Torstensson Consulting. Previously, Mr. Torstensson was the Chairman of the Board of Directors and a member of the Board of Directors of Xeric AB, the Chairman of the Boards of Directors of ONE Media Holding AB (publ), Mankato Investments AG and Virteco AB, and a member of the Board of Directors of ONE CC AB. Furthermore, Mr. Torstensson has been the Chief Executive Officer of Brightpoint EMA Ltd, Ericsson Mobile Communication AB, Uppland Kredit AB (publ) and Lendlink AB, as well as the Executive VP and General Manager at Ericsson Inc. (North America).

Education: Master of Science degree in Industrial Engineering from Linköping University and has also completed the General Management Program at CEDEP/INSEAD, France.

 

Jens Umehag

B. 1974, Swedish citizen
Member of the Board of Directors since 2019

Jens Umehag serves as the Chief Financial Officer of Innovation at Halma Plc. Previously, Mr. Umehag was a member of the Boards of Directors of Fotech Solutions Ltd, Heliex Power Ltd and Rocket Route Ltd. In addition, he has served as the Chief Financial Officer and Head of Finance Group Technology at BP Ventures Ltd, as Finance Director of Germany & International Key accounts at BP Plc’s Castrol subsidiaries in Germany and he has also held several positions ranging from analyst to finance director at BP Ventures Ltd.

Education: Bachelor of Arts degree in European Business Administration from the European Business School, London.

 

Jun Wu

B. 1966, United States citizen
Member of the Board of Directors since 2014

Jun Wu is the founder, Chairman and Managing Partner of Cenova Capital and serves as a member of the Boards of Directors of Aslan Pharmaceuticals Ltd, Cheng Heng Health Science and Technology Holdings Ltd, Choice Technology Inc, Etongonline Shanghai Medical Consulting Co. Ltd, HK Doctorlink Internet Tech Co. Ltd, Jing Medicine Technology (Shanghai) Ltd, Luqa Ventures Co. Ltd, Shanghai Aohua Photoelectricity Endoscope Co., Shanghai EnsurLink Ltd, Shanghai Lianji Biotechnology Co. Ltd, Shanghai Yao Shi Quan Cloud Health Technology Development Ltd, Start (Shanghai) Pharmaceutical Technology Ltd, Suzhou SceneRay Corporation Ltd, Virtuoso Therapeutics Inc and Vivace Therapeutics Inc. In addition, he serves as a Director at Alnair Investment, Cenova China Healthcare GP IV Ltd, Cenova Management Advisors Ltd, Novoasis Investment Ltd and Ruikang Investment Ltd. Furthermore, Mr. Wu is the co-founder of Shanghai Genomics, Inc. and he has previously served as the Chief Executive Officer, as a member of the Board of Directors and held various managerial postions at Shanghai Genomics, Inc., as well as various managerial positions at GNI Ltd.

Education: Doctor of Philosophy degree in Microbiology and Immunology from the University of California at San Francisco and a Bachelor of Science degree in Biology from San Jose State University.